Fig. 3 | Scientific Reports

Fig. 3

From: Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

Fig. 3

Changes in the retinal findings from baseline to 6 months in treatment-naïve and previously treated groups. The y-axis represents the percentage of eyes. Brackets with asterisks denote statistically significant differences between the treatment-naïve and previously treated groups at each time point (baseline or 6 months); p < 0.05, ** p < 0.01. INL, inner nuclear layer; OPL, outer plexiform layer; DRT, diffuse retinal thickening; SRF, subretinal fluid; DRIL, disorganisation of the retinal inner layers; EZ, disruption of the ellipsoid zone; ERM, epiretinal membrane; VMT, vitreomacular traction.

Back to article page